Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D Supplementation to Prevent Health Disparities in Pregnancy
NCT01932788Phase 3Completed
- Sponsor
- Medical University of South Carolina
- Start
- Jan 2013
- Primary completion
- Apr 2017
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Vitamin D deficiency (VDD) comparing Vitamin D 4000 IU with Placebo (Standard Care) (2 arms). Primary endpoint: Number of Participants With Greater Than 100 Nmol/L 25(OH)D at 20 weeks. Started Jan 2013; status: completed.
02
Drugs
vitamin d
03
Conditions
Vitamin D deficiency (VDD)
Beyond the preview
Go deeper on NCT01932788.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01932788.